| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM198909073211004 |
| P698 | PubMed publication ID | 2488072 |
| P50 | author | Lewis Kuller | Q88077314 |
| Rena R. Wing | Q28007338 | ||
| P2093 | author name string | Kelsey SF | |
| Matthews KA | |||
| Caggiula AW | |||
| Meilahn E | |||
| P433 | issue | 10 | |
| P921 | main subject | heart disease | Q190805 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 641-646 | |
| P577 | publication date | 1989-09-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Menopause and risk factors for coronary heart disease | |
| P478 | volume | 321 |
| Q37170186 | 17Beta-estradiol increases basal but not bradykinin-stimulated release of active t-PA in young postmenopausal women |
| Q35082579 | 17β-estradiol and progesterone independently augment cutaneous thermal hyperemia but not reactive hyperemia |
| Q37070492 | 8 Effects of sex steroids on serum lipids and lipoproteins |
| Q35084802 | A 90 minute soccer match decreases triglyceride and low density lipoprotein but not high-density lipoprotein and cholesterol levels. |
| Q37197085 | A comparative study of lipid profile and oestradiol in pre- and post-menopausal women |
| Q33544854 | A critical European view of the HERS trial |
| Q44794839 | A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus |
| Q36468286 | A greater reduction in high-frequency heart rate variability to a psychological stressor is associated with subclinical coronary and aortic calcification in postmenopausal women |
| Q39141960 | A metabolic view on menopause and ageing |
| Q34294236 | A protocol for a randomized clinical trial of interactive video dance: potential for effects on cognitive function. |
| Q77853784 | ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stab |
| Q51556484 | Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. |
| Q47163277 | Adequacy of control of cardiovascular risk factors in ambulatory patients with type 2 diabetes attending diabetes out-patients clinic at a county hospital, Kenya. |
| Q36635341 | Adipocyte fatty acid storage factors enhance subcutaneous fat storage in postmenopausal women |
| Q46419104 | Analysis of medications dispensed to control the main cardiovascular risks in the Murcia Region: are there gender differences? |
| Q41529350 | Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996. |
| Q40572159 | Androgens and women's health: genetic and epidemiologic aspects of lipid metabolism |
| Q51087846 | Anger, hostility, and visceral adipose tissue in healthy postmenopausal women. |
| Q45125376 | Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause |
| Q41092073 | Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women |
| Q33797766 | Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? |
| Q43884030 | Are there gender differences in patients presenting with unstable angina? |
| Q36640598 | Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial |
| Q36957473 | Associations of estrogen and testosterone with insulin resistance in pre- and postmenopausal women with and without hormone therapy |
| Q36522643 | Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts |
| Q34562097 | Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria |
| Q91654934 | Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019 |
| Q43176554 | Brisk walking and high density lipoprotein cholesterol |
| Q37791732 | Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment |
| Q33835998 | Cardiac vagal activity during psychological stress varies with social functioning in older women |
| Q36338451 | Cardiovascular Disease Mortality Among Breast Cancer Survivors |
| Q64988174 | Cardiovascular Disease in Women: Understanding Symptoms and Risk Factors. |
| Q35965092 | Cardiovascular disease and primary ovarian insufficiency |
| Q50970876 | Carotid endarterectomy in adults 50 years of age and younger: a retrospective comparative study. |
| Q47423284 | Changes in body weight and onset of hypertension in perimenopausal women |
| Q28508461 | Chronic estrogen deficiency leads to molecular aberrations related to neurodegenerative changes in follitropin receptor knockout female mice |
| Q36952970 | Clinical considerations regarding treatment of hypercholesterolemia in the elderly |
| Q40482684 | Clinical perspectives on primary and secondary prevention of coronary atherosclerosis |
| Q37115391 | Combined Effects of Rosuvastatin and Exercise on Gene Expression of Key Molecules Involved in Cholesterol Metabolism in Ovariectomized Rats |
| Q49189576 | Comparison of lipid profiles and inflammation in pre- and post-menopausal women with cerebral infarction and the role of atorvastatin in such populations |
| Q40672545 | Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease |
| Q43546717 | Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel. |
| Q51565053 | Coronary heart disease risk factors and menopause: a study in 1684 French women. |
| Q53757259 | Design of a lifestyle intervention to slow menopause-related progression of intra-abdominal adipose tissue in women: The Women in the Southside Health and Fitness (WISHFIT) study. |
| Q56483522 | Design of the Women’s Health Initiative Clinical Trial and Observational Study |
| Q39103733 | Detection of coronary artery disease in postmenopausal women: the significance of integrated stress imaging tests in a 4-year prognostic study |
| Q73311100 | Diabetes and cardiovascular disease |
| Q34534422 | Diet intervention to improve cardiovascular risk factors among Iranian postmenopausal women. |
| Q36611044 | Dietary isoflavone intake, urinary isoflavone level, and their relationship with metabolic syndrome diagnostic components in korean postmenopausal women |
| Q51091169 | Differential effects of harassment on cardiovascular and salivary cortisol stress reactivity and recovery in women and men. |
| Q36088805 | Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changes |
| Q41180424 | Drug-induced disorders of glucose metabolism. Mechanisms and management |
| Q47095410 | Duration of Reproductive Life Span, Age at Menarche, and Age at Menopause Are Associated With Risk of Cardiovascular Disease in Women. |
| Q43672787 | Duration of menopause and behavior of malondialdehyde, lipids, lipoproteins and carotid wall artery intima-media thickness. |
| Q37582481 | Dyslipidemia in women: etiology and management |
| Q42877917 | Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring |
| Q40802343 | Dyslipoproteinemia in women and the elderly. |
| Q33694914 | EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium |
| Q36237441 | Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis |
| Q46429409 | Early postoperative results for females undergoing isolated coronary artery bypass surgery: comparison of the pre- and postmenopausal periods |
| Q35243693 | Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes. |
| Q71551055 | Effect of menopause on left ventricular filling in 50-year-old women |
| Q71650550 | Effect of postmenopausal estrogen replacement therapy on lipoproteins |
| Q37219622 | Effect of resistance training on muscular strength and indicators of abdominal adiposity, metabolic risk, and inflammation in postmenopausal women: controlled and randomized clinical trial of efficacy of training volume |
| Q44203348 | Effect of tibolone administration on heart rate variability and free fatty acid levels in postmenopausal women |
| Q35040342 | Effectiveness of a physical activity and weight loss intervention for middle-aged women: healthy bodies, healthy hearts randomized trial |
| Q46127170 | Effects of aquatic resistance training on health and fitness in postmenopausal women |
| Q44809174 | Effects of estrogen replacement therapy on natriuretic peptides and blood pressure |
| Q53770536 | Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. |
| Q73807090 | Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal women |
| Q73409238 | Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: the Chin-Shan Community Cardiovascular Cohort Study |
| Q43913015 | Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight--the Chin-Shan Community Cardiovascular Cohort study |
| Q46746525 | Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women |
| Q98613669 | Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia |
| Q37661627 | Efficacy of a low dose of estrogen on antioxidant defenses and heart rate variability |
| Q35044453 | Elevated mean arterial pressure in the ovariectomized rat was normalized by ET(A) receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis |
| Q37786757 | Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids |
| Q40572181 | Endogenous sex hormones: impact on lipids, lipoproteins, and insulin |
| Q35872688 | Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro |
| Q40877167 | Epidemiological overview of oestrogen replacement and cardiovascular disease |
| Q71598016 | Estradiol-17beta as an antioxidant: some distinct features when compared with common fat-soluble antioxidants |
| Q33558058 | Estrogen hormone replacement to minimize cardiovascular risk |
| Q40747941 | Estrogen replacement therapy in women at increased risk for breast cancer |
| Q33976390 | Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity |
| Q34132661 | Estrogens and women's health: interrelation of coronary heart disease, breast cancer and osteoporosis |
| Q37412687 | Ethnic, gender, and age-related differences in patients with the metabolic syndrome. |
| Q73263012 | Exercise mitigates the association of abdominal obesity with high-density lipoprotein cholesterol in premenopausal women: results from the third National Health and Nutrition Examination Survey |
| Q44752123 | Fatty acid and cholesterol composition of the uterine artery intima in relation to menopausal status, age, and serum cholesterol |
| Q58711470 | Flow mediated vasodilation compared with carotid intima media thickness in the evaluation of early cardiovascular damage in menopausal women and the influence of biological and psychosocial factors |
| Q93390474 | Follicle-stimulating hormone, but not cardiorespiratory fitness, is associated with flow-mediated dilation with advancing menopausal stage |
| Q38116436 | Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review |
| Q33824701 | Gain in adiposity across 15 years is associated with reduced gray matter volume in healthy women |
| Q37401692 | Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation |
| Q34479055 | Gender differences in coronary heart disease |
| Q35095785 | Gender specific patterns of age-related decline in aortic stiffness: a cardiovascular magnetic resonance study including normal ranges |
| Q34661003 | Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response |
| Q43786652 | Glycaemic control and plasma lipoproteins in menopausal women with Type 2 diabetes treated with oral and transdermal combined hormone replacement therapy |
| Q73194846 | HRT and exercise: effects on bone density, muscle strength and lipid metabolism. A placebo controlled 2-year prospective trial on two estrogen-progestin regimens in healthy postmenopausal women |
| Q34407513 | HRT in women with diabetes--review of the effects on glucose and lipid metabolism |
| Q66475520 | Healthy lifestyle during the midlife is prospectively associated with less subclinical carotid atherosclerosis: the Study of Women's Health Across the Nation. |
| Q36998601 | Heightened functional neural activation to psychological stress covaries with exaggerated blood pressure reactivity |
| Q33798118 | Hemostatic Factors and Ischemic Heart Disease Risk Among Postmenopausal Women |
| Q44856785 | Hepatic lipase activity during oral and parenteral 17 beta-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic |
| Q37506608 | High-density lipoprotein cholesterol, obesity, and mammographic density in Korean women: the Healthy Twin study |
| Q47295458 | Hormone replacement therapy and body size: how much does lifestyle explain? |
| Q34145809 | Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment |
| Q34107469 | Hormone replacement therapy in the prevention and treatment of atherosclerosis |
| Q24197712 | Hormone therapy for preventing cardiovascular disease in post-menopausal women |
| Q35045916 | Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen |
| Q85432136 | Impact of Menopause on Pharmacokinetics of Rosuvastatin Compared with Premenopausal Women |
| Q35574191 | Impact of female hormones on blood pressure: Review of potential mechanisms and clinical studies |
| Q73896980 | Impaired fasting glycaemia in middle-aged women: a prospective study |
| Q36960896 | Incident coronary artery calcium among postmenopausal women |
| Q36574106 | Influence of Day Length and Physical Activity on Sleep Patterns in Older Icelandic Men and Women |
| Q46908168 | Insulin resistance, obesity, and metabolic syndrome among non-diabetic pre- and post-menopausal women in North Taiwan |
| Q36812747 | Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? |
| Q46126263 | Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women? |
| Q33975584 | Issues in accelerometer methodology: the role of epoch length on estimates of physical activity and relationships with health outcomes in overweight, post-menopausal women |
| Q88899703 | Jiawei Erzhiwan improves menopausal metabolic syndrome by enhancing insulin secretion in pancreatic β cells |
| Q43983868 | Levels of serum cholesterol in a catalan population. Evolution over a 6- year period (1994-1996) |
| Q35406827 | Lifetime socioeconomic position in relation to onset of perimenopause. |
| Q40445668 | Lipid Changes Around the Final Menstrual Period Predict Carotid Subclinical Disease in Postmenopausal Women |
| Q37306150 | Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation |
| Q55462786 | Lipid profile and plasma atherogenic index in postmenopausal osteoporosis. |
| Q68182105 | Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women? |
| Q34990631 | Lipoprotein abnormalities related to women's health |
| Q43748428 | Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study |
| Q43911034 | Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women |
| Q73588866 | Longitudinal changes in weight in perimenopausal and early postmenopausal women: effects of dietary energy intake, energy expenditure, dietary calcium intake and hormone replacement therapy |
| Q39446732 | Longitudinal trends in total serum cholesterol levels in a Japanese cohort, 1958-1986. |
| Q91760050 | Males Require Estrogen Signaling Too: Sexual Dimorphism in the Regulation of Glucose Homeostasis by Nuclear ERα |
| Q34073832 | Managing mixed dyslipidemia in special populations |
| Q34539670 | Menopause and perimenopause: the role of ovarian hormones in common neuroendocrine syndromes in primary care |
| Q36181734 | Menopause versus aging: The predictor of obesity and metabolic aberrations among menopausal women of Karnataka, South India |
| Q36821466 | Menopause, atherosclerosis, and coronary artery disease |
| Q34792332 | Menopause, energy expenditure, and body composition |
| Q26795571 | Metabolic disorders in menopause |
| Q35507040 | Metabolic effects of soy supplementation in postmenopausal Caucasian and African American women: a randomized, placebo-controlled trial |
| Q40927730 | Metabolic effects of the menopause and oestrogen replacement |
| Q34221182 | Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study. |
| Q72779668 | Modifying influences on serum lipids among postmenopausal women |
| Q41526058 | Nonlipoprotein risk factors for coronary heart disease: Evaluation and management |
| Q35747749 | Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones. |
| Q42332484 | Oestrogen, atherosclerosis and cardiovascular disease in women: Epidemiological studies on menopause and hormone replacement therapy |
| Q40877161 | Oestrogens and atherosclerotic vascular disease--lipid factors |
| Q36271859 | Oestrogens and insulin secretion |
| Q73893665 | Opinion survey towards hormone replacement therapy in the prevention of coronary heart disease |
| Q37105605 | Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility |
| Q35793618 | Ovariectomy shortens the life span of female mice |
| Q43612141 | Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy |
| Q67477871 | Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate |
| Q37228261 | Post-genome-wide association study challenges for lipid traits: describing age as a modifier of gene-lipid associations in the Population Architecture using Genomics and Epidemiology (PAGE) study |
| Q40458696 | Postmenopausal Hormone-Replacement Therapy and Cardiovascular Risk |
| Q40390676 | Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. |
| Q40864441 | Postmenopausal hormone replacement: are two hormones better than one? |
| Q35992933 | Postprandial lipemia in pre- and postmenopausal women |
| Q51580855 | Postprandial reduction in high-density lipoprotein cholesterol concentrations in postmenopausal women: improvement by 17beta-estradiol. |
| Q38906833 | Predictors of Carotid Intima-Media Thickness and Plaque Progression in a Chinese Population |
| Q37229119 | Premenopausal risk factors for coronary and aortic calcification: a 20-year follow-up in the healthy women study |
| Q37240490 | Prevalence of Low Cardiovascular Risk Profile Among Diverse Hispanic/Latino Adults in the United States by Age, Sex, and Level of Acculturation: The Hispanic Community Health Study/Study of Latinos |
| Q73179490 | Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat |
| Q32043226 | Prevention of development of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat by the new nonsteroidal antiestrogen EM-800 (SCH57050). |
| Q73510823 | Primary prevention of weight gain for women aged 25-34: the acceptability of treatment formats |
| Q36484453 | Progression rates of carotid intima-media thickness and adventitial diameter during the menopausal transition. |
| Q35793045 | Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus |
| Q35450239 | Puberty and perimenopause: reproductive transitions and their implications for women's health. |
| Q34236652 | Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities |
| Q34271942 | Raising HDL cholesterol in women. |
| Q34118797 | Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats |
| Q73009884 | Rapid changes of flow-mediated dilatation after surgical menopause |
| Q45253405 | Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study |
| Q70494198 | Relations of cardiovascular risk factors to aortic pulse wave velocity in asymptomatic middle-aged women |
| Q36047141 | Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women |
| Q50908249 | Relationship of endogenous sex hormones to lipids and blood pressure in mid-aged women. |
| Q33786777 | Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature |
| Q74106912 | Reproductive history in relation to plasma hormone levels in healthy post-menopausal women |
| Q37498756 | Self-reported and accelerometer-derived physical activity levels and coronary artery calcification progression in older women: results from the Healthy Women Study |
| Q36870344 | Serum lipid responses to psyllium fiber: differences between pre- and post-menopausal, hypercholesterolemic women |
| Q50544308 | Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women |
| Q74624217 | Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988 |
| Q67899288 | Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives |
| Q34217759 | Sex differences in cardiovascular disease: are women with low socioeconomic status at high risk? |
| Q35903054 | Sex differences in primary hypertension |
| Q41043436 | Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: have they been adequately evaluated? |
| Q36891841 | Sexual Dimorphic Metabolic Alterations in Hepatitis C Virus-infected Patients: A Community-Based Study in a Hepatitis B/Hepatitis C Virus Hyperendemic Area |
| Q80577225 | Sexual dimorphism in arterial hypertension: an age-related phenomenon |
| Q101564351 | Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver |
| Q40812121 | Short term effects of exercise on plasma lipids and lipoproteins in humans |
| Q35635480 | Sleep and executive function in older women: the moderating effect of physical activity |
| Q40480966 | Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patient |
| Q50042766 | Stroke Risk Factors Unique to Women. |
| Q35689475 | Superovulation Induced Changes of Lipid Metabolism in Ovaries and Embryos and Its Probable Mechanism |
| Q40657335 | Supplemental estrogen replacement. |
| Q86838757 | Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study |
| Q73549362 | Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol |
| Q30908884 | Synthesising licensing data to assess drug safety |
| Q36695459 | Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids |
| Q37325107 | Temporal relationships between physical activity and sleep in older women |
| Q33836874 | Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. |
| Q36058345 | The Impact of Body Weight Change on Bone Mineral Density of the Lumbar Spine in Perimenopausal Women: A Retrospective, One-year Follow-up Study |
| Q37446318 | The Mediation of Hepatic Lipogenesis Through Estrogens |
| Q35810459 | The Metabolic Syndrome among Postmenopausal Women in Gorgan |
| Q61804197 | The Relationship of Dietary Cholesterol with Serum Low-Density Lipoprotein Cholesterol and Confounding by Reverse Causality: The INTERLIPID Study |
| Q35238858 | The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins |
| Q74185612 | The anti-mitogenic activity of 17beta-estradiol in coronary smooth muscle cells correlates with protein binding to its responsive element |
| Q34666872 | The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women |
| Q35928976 | The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study |
| Q51566961 | The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. |
| Q33845784 | The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women |
| Q73477000 | The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women |
| Q41679916 | The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study |
| Q73091606 | The effect of menopause on blood lipid and lipoprotein levels. The Icarus Study Group |
| Q77366626 | The effect of percutaneous oestradiol on atheroma formation in ovariectomized cholesterol-fed rabbits |
| Q42165321 | The effects of a soy rich diet on serum lipids: the Menfis randomized trial. |
| Q46061292 | The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study |
| Q51570678 | The effects of menopausal status and exercise training on serum lipids and the activities of intravascular enzymes related to lipid transport. |
| Q73090147 | The incidence of cerebrovascular accidents in patients with pituitary adenoma |
| Q33535652 | The menopause |
| Q35536861 | The menopause and hormone replacement therapy |
| Q90373044 | The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN) |
| Q58768337 | The protective effect of Er-Xian decoction against myocardial injury in menopausal rat model |
| Q74240125 | The relationship between the female menopause and serum sialic acid, a known cardiovascular risk factor |
| Q40760251 | Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women |
| Q57606043 | Transdermal estrogen replacement therapy and plasma lipids in 693 French women |
| Q33767543 | Underreporting of dietary intake by body mass index in premenopausal women participating in the Healthy Women Study |
| Q50959775 | Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: a nested case-referent study in the DOM-cohort. |
| Q34416079 | Utility of actiwatch sleep monitor to assess waking movement behavior in older women |
| Q88317504 | Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life |
| Q44426065 | Vascular function of forearm microcirculation in postmenopausal women with type 2 diabetes: potential benefit of hormone replacement therapy? |
| Q37670692 | Vitamin D and insulin resistance in postmenopausal Indian women |
| Q33801935 | Who Should Receive Hormone Replacement Therapy? |
| Q36647114 | Why women live longer than men: the biologic mechanism of the sex differential in longevity |
| Q74491667 | [Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart d |
Search more.